The South Carolina-based company, founded in 2007, specializes in developing innovative technologies that leverage silicate particles to promote immune system-driven cancer treatment and address various medical needs. Their immuno-therapeutics utilize non-toxic, silicate-based molecules to stimulate the body's immune response against cancer cells. Additionally, they create topical therapies for fighting infections, enhancing post-surgical cosmetic procedures, beauty treatments, and bone regeneration. HS Pharmaceuticals, LLC aims to provide patients with accelerated medical solutions for a wide range of ailments.